Vaccines

SJR Rank #5,258H-index: 111SJR: 0.955Best quartile: Q1Open AccessAPC: US$3,258Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Multidisciplinary Digital Publishing Institute (MDPI)

Country

Switzerland

Type

journal

SJR by Edition

2022202500.450.91.351.8

Subject Categories

  • Pharmacology (medical)Q1
  • Drug DiscoveryQ2
  • ImmunologyQ2
  • Infectious DiseasesQ2
  • PharmacologyQ2

Areas: Immunology and Microbiology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyInfluenza Virus Research StudiesImmunotherapy and Immune ResponsesCOVID-19 Clinical Research StudiesRespiratory viral infections researchViral gastroenteritis research and epidemiologyCOVID-19 epidemiological studiesAnimal Virus Infections Studiesvaccines and immunoinformatics approaches

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs01500300045006000

Documents per Year

202220250550110016502200

Detailed Information

ISSN

2076-393X

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

3.61

References per Document

60.96

Coverage

2013-2026

Scope

Vaccines (ISSN 2076-393X) is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization. Vaccines publishes high quality reviews, regular research papers, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in open access form in as much detail as possible. The full experimental details must be provided so that the results can be reproduced. There are, in addition, unique features of this journal: -manuscripts regarding research proposals and research ideas will be particularly welcomed -computed data or files regarding the full details of the experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material -we also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds Subject Areas: -immunology mechanisms- animal models for immunologic diseases- viral immunology- immunopathogenesis- vaccine development and efficacy evaluation- immune responses to vaccines- vaccine technology- vaccine vectors, adjuvants and immunomodulators- prophylactic vaccines, therapeutic vaccines, AIDS vaccines, gene vaccines, vaccines in bioterrorism- regulatory affairs, commercial utilization, policy, safety, epidemiology.

Metrics from SCImago Journal Rank 2025. View on SCImago